Resources
- FAQ
- Protocol
- Cell Culture Guide
- Technical Bulletins
-
Explore & Learn
-
Cell Biology
- How to Handle Mycoplasma in Cell Culture?
- Enrichment, Isolation and Characterization of Circulating Tumor Cells (CTCs)
- Strategies for Enrichment of Circulating Tumor Cells (CTCs)
- How to Assess the Migratory and Invasive Capacity of Cells?
- Multi-Differentiation of Peripheral Blood Mononuclear Cells
- What Cell Lines Are Commonly Used in Biopharmaceutical Production?
- Tips For Cell Cryopreservation
- Troubleshooting Cell Culture Contamination: A Comprehensive Guide
- CHO Cell Line Development
- Contamination of Cell Cultures & Treatment
- Generation and Applications of Neural Stem Cells
- Stem Cell Markers
- Comparison of the MSCs from Different Sources
- T Cell Activation and Expansion
- How to Isolate and Analyze Tumor-Infiltrating Leukocytes?
- Mesenchymal Stem Cells: A Comprehensive Exploration
- What are the Differences Between M1 and M2 Macrophages?
- Organoid Differentiation from Induced Pluripotent Stem Cells
- Quantification of Cytokines
- How to Decide Between 2D and 3D Cell Cultures?
- Neural Differentiation from Induced Pluripotent Stem Cells
- What are PBMCs?
- Monocytes vs. Macrophages
- How to Detect and Remove Endotoxins in Biologics?
- Comparison of Different Methods to Measure Cell Viability
- How to Isolate PBMCs from Whole Blood?
- CFU Assay for Hematopoietic Cell
- Biomarkers and Signaling Pathways in Tumor Stem Cells
- Circulating Tumor Cells as Cancer Biomarkers in the Clinic
- How to Start Your Culture: Thawing Frozen Cells
- Techniques for Cell Separation
- Guidelines for Cell Banking to Ensure the Safety of Biologics
- T Cell, NK Cell Differentiation from Induced Pluripotent Stem Cells
- Major Problems Caused by the Use of Uncharacterized Cell Lines
- Critical Quality Attributes and Assays for Induced Pluripotent Stem Cells
- Cell Culture Medium
- Direct vs. Indirect Cell-Based ELISA
- What Is Cell Proliferation and How to Analyze It?
- IL-12 Family Cytokines and Their Immune Functions
- What are Mesothelial Cells?
- How to Scale Up Single-Cell Clones?
- STR Profiling—The ID Card of Cell Line
- Comparison of Several Techniques for the Detection of Apoptotic Cells
- What Are Myeloid Cell Markers?
- Cryopreservation of Cells Step by Step
- Cell Cryopreservation Techniques and Practices
- Human Primary Cells: Definition, Assay, Applications
- How to Eliminate Mycoplasma From Cell Cultures?
- Unveiling the Molecular Secrets of Adipogenesis in MSCs
- Isolation, Expansion, and Analysis of Natural Killer Cells
- Tumor Stem Cells: Identification, Isolation and Therapeutic Interventions
- Understanding Immunogenicity Assays: A Comprehensive Guide
- Role of Cell-Based Assays in Drug Discovery and Development
- Mastering Cell Culture and Cryopreservation: Key Strategies for Optimal Cell Viability and Stability
- Adherent and Suspension Cell Culture
- Organoid Drug Screening
- Overview of Cell Apoptosis Assays
- Key Techniques in Primary, Immortalized and Stable Cell Line Development
- From Primary to Immortalized: Navigating Key Cell Lines in Biomedical Research
- Histological Staining Techniques: From Traditional Chemical Staining to Immunohistochemistry
- From Specimen to Slide: Core Methods in Histological Practice
- Modern Histological Techniques
- Exploring Cell Dynamics: Migration, Invasion, Adhesion, Angiogenesis, and EMT Assays
- Cell Viability, Proliferation and Cytotoxicity Assays
-
Histology
- Multiple Animal Tissue Arrays
- Tips for Choosing the Right Protease Inhibitor
- Instructions for Tumour Tissue Collection, Storage and Dissociation
- Fluorescent Nuclear Staining Dyes
- Troubleshooting in Fluorescent Staining
- Guides for Live Cell Imaging Dyes
- Overview of the FFPE Cell Pellet Product Lines
- Mitochondrial Staining
- Stains Used in Histology
- Immunohistochemistry Controls
- Comparison of Membrane Stains vs. Cell Surface Stains
- Immunohistochemistry Troubleshooting
- Cell and Tissue Fixation
- Microscope Platforms
- Cell Lysates: Composition, Properties, and Preparation
- Overview of Common Tracking Labels for MSCs
- How to Apply NGS Technologies to FFPE Tissues?
-
Exosome
- Exosomes as Emerging Biomarker Tools for Diseases
- How to Apply Exosomes in Clinical?
- How to Efficiently Utilize MSC Exosomes for Disease Treatment?
- Emerging Technologies and Methodologies for Exosome Research
- What's the Potential of PELN in Disease Treatment?
- Summary of Approaches for Loading Cargo into Exosomes
- How to Perform Targeted Modification of Exosomes?
- How to Enhancement Exosome Production?
- How to Label Exosomes?
- How to characterize exosomes?
- Classification, Isolation Techniques and Characterization of Exosomes
- Exosome Quality Control: How to Do It?
- Exosome Transfection for Altering Biomolecular Delivery
- Collection of Exosome Samples and Precautions
- How do PELN Deliver Drugs?
- Current Research Status of Milk Exosomes
- Exosome Antibodies
- How Important are Lipids in Exosome Composition and Biogenesis?
- Common Techniques for Exosome Nucleic Acid Extraction
- What are the Functions of Exosomal Proteins?
- The Role of Exosomes in Cancer
- Exosome Size Measurement
- Techniques for Exosome Quantification
- Unraveling Biogenesis and Composition of Exosomes
- Applications of MSC-EVs in Immune Regulation and Regeneration
- Production of Exosomes: Human Cell Lines and Cultivation Modes
-
ISH/FISH
- ISH probe labeling method
- What Types of Multicolor FISH Probe Sets Are Available?
- What Is the Use of FISH in Solid Tumors?
- Mapping of Transgenes by FISH
- Comprehensive Comparison of IHC, CISH, and FISH Techniques
- Reagents Used in FISH Experiments
- Telomere Length Measurement Methods
- Differences Between DNA and RNA Probes
- FISH Tips and Troubleshooting
- Comparative Genomic Hybridization and Its Applications
- RNAscope ISH Technology
- CARD-FISH: Illuminating Microbial Diversity
- Overview of Oligo-FISH Technology
- What are the Differences between FISH, aCGH, and NGS?
- Multiple Options for Proving Monoclonality
- FISH Techniques for Biofilm Detection
- Whole Chromosome Painting Probes for FISH
- Multiple Approaches to Karyotyping
- In Situ Hybridization Probes
- Overview of Common FISH Techniques
- What are Single, Dual, and Multiplex ISH?
- Different Types of FISH Probes for Oncology Research
- How to Use FISH in Hematologic Neoplasms?
- Small RNA Detection by ISH Methods
- Guidelines for the Design of FISH Probes
-
Toxicokinetics & Pharmacokinetics
- What Are Metabolism-Mediated Drug-Drug Interactions?
- How to Improve Drug Plasma Stability?
- Experimental Methods for Identifying Drug-Drug Interactions
- How to Conduct a Bioavailability Assessment?
- Organ-on-a-Chip Systems for Drug Screening
- Pharmacokinetics Considerations for Antibody Drug Conjugates
- Toxicokinetics vs. Pharmacokinetics
- How to Improve the Pharmacokinetic Properties of Peptides?
- Organoids in Drug Discovery: Revolutionizing Therapeutic Research
- Key Considerations in Toxicokinetic
- How Is the Cytotoxicity of Drugs Determined?
- Traditional vs. Novel Drug Delivery Methods
- Comparison of MDCK-MDR1 and Caco-2 Cell-Based Permeability Assays
- Unraveling the Role of hERG Channels in Drug Safety
- What factors influence drug distribution?
- How to Design and Synthesize Antibody Drug Conjugates?
- Pharmacokinetics of Therapeutic Peptides
- Methods of Parallel Artificial Membrane Permeability Assays
- What Is the Role of the Blood-Brain Barrier in Drug Delivery?
- Parameters of Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion
- What are the Pharmacokinetic Properties of the Antisense Oligonucleotides?
- Key Factors Influencing Brain Distribution of Drugs
- Effects of Cytochrome P450 Metabolism on Drug Interactions
- How to Improve Drug Distribution in the Brain
- Physical and Chemical Properties of Drugs and Calculations
- The Rise of In Vitro Testing in Drug Development
- Predictive Modeling of Metabolic Drug Toxicity
- Overview of In Vitro Permeability Assays
- What Are Compartment Models in Pharmacokinetics?
-
Disease Models
- What Human Disease Models Are Available for Drug Development?
- Overview of Cardiovascular Disease Models in Drug Discovery
- Animal Models of Neurodegenerative Diseases
- Preclinical Models of Acute Liver Failure
- Summary of Advantages and Limitations of Different Oncology Animal Models
- Why Use PDX Models for Cancer Research?
- Disease Models of Diabetes Mellitus
-
Cell Biology
- Life Science Articles
- Download Center
- Trending Newsletter
Indirect ELISA Protocol
GUIDELINE
The steps for an indirect enzyme-linked immunosorbent assay (ELISA) are the same as for a direct ELISA, except for the additional washing step and the type of antibody added after removing the buffer. Indirect ELISA requires two antibodies, a detection primary antibody that adheres to the target protein and an enzyme-linked secondary antibody that is complementary to the primary antibody.
METHODS
Antigen encapsulation
- Dilute the antigen with PBS or carbonate buffer to a final concentration of 20 μg/ml. Pipette 50 μl of the diluted antigen onto a PVC plate and make serial dilutions as required.
- Cover the plate with the membrane and incubate for 2 hours at room temperature or overnight at 4°C. The incubation time should be optimized. The incubation time should be optimized.
- Pour off the incubation solution and wash the plate twice with PBS, 200 μl per well. Pour off the wash solution by flicking it on the sink and tap the plate on a paper towel to remove the residual liquid.
Blocking
- Block the remaining protein binding sites on the plate with PBS buffer containing 5% skimmed milk powder or 5% serum, 200 μl per well, or substitute with other blocking agents such as Block ACE, and BSA (bovine serum albumin).
- Cover the plate with the membrane and incubate for at least 2 hours at room temperature or overnight at 4°C.
- Wash the plate twice with PBS.
Incubation with primary and secondary antibodies
- Add 100 μl of diluted primary antibody to each well.
- Incubate the membrane-covered plates at room temperature for 2 hours, the incubation time needs to be optimized. Usually, 2 hours of incubation is sufficient to obtain a strong signal, but if the signal obtained is weak, incubate at 4°C overnight to obtain a stronger signal.
- Wash the plate 4 times with PBS.
- Add labeled secondary antibody, 100 μl per well. dilute to the optimal concentration and mix with the sealing solution before use.
- Cover the plate with membrane and incubate at room temperature for 1-2 hours.
- Wash the plate 4 times with PBS.
Detection
- Add substrate with a multichannel pipette, 100 μl (or 50 μl) per well.
- After a sufficiently dark color is displayed, add termination solution (if necessary), 100 μl per well.
- The absorbance value (optical density) is read by the enzyme marker.
NOTES
- Good purity is required for the adsorption of antibodies (or antigens) onto the surface of solid phase carriers. When adsorbed, the PH is generally required to be between 9.0 and 9.6.
- Adsorption temperature, time, and protein amount also have a certain impact, generally used at 4°C, 18 to 24 hours.
RELATED PRODUCTS & SERVICES
For research use only. Not for any other purpose.